Skip to main content

Advertisement

Log in

Viral protein R polymorphisms in the pathogenesis of HIV-associated acute ischaemic stroke: a case–control study

  • Published:
Journal of NeuroVirology Aims and scope Submit manuscript

Abstract

HIV-1 viral proteins have been implicated in endothelial dysfunction, which is a major determinant of ischaemic stroke risk in HIV-infected individuals. Polymorphisms in HIV-1 viral protein R (Vpr) may alter its potential to promote endothelial dysfunction, by modifying its effects on viral replication, reactivation of latent cells, upregulation of pro-inflammatory cytokines and infection of macrophages. We analysed Vpr polymorphisms and their association with acute ischaemic stroke by comparing Vpr signature amino acids between 54 HIV-infected individuals with acute ischaemic stroke, and 80 age-matched HIV-infected non-stroke controls. Isoleucine at position 22 and serine at position 41 were associated with ischaemic stroke in HIV. Individuals with stroke had lower CD4 counts and CD4 nadirs than controls. These polymorphisms are unique to individuals with stroke compared to South African subtype C and the control group consensus sequences. Signature Vpr polymorphisms are associated with acute ischaemic stroke in HIV. These may increase stroke risk by promoting endothelial dysfunction and susceptibility to opportunistic infections. Therapeutic targeting of HIV-1 viral proteins may present an additional mechanism of decreasing stroke risk in HIV-infected individuals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  • Acheampong E, Mukhtar M, Parveen Z et al (2002) Ethanol strongly potentiates apoptosis induced by HIV-1 proteins in primary human brain microvascular endothelial cells. Virology 304:222–234

    Article  CAS  Google Scholar 

  • Benjamin LA, Bryer A, Emsley HC et al (2012) HIV infection and stroke: current perspectives and future directions. Lancet Neurol 11:878–890

    Article  Google Scholar 

  • Benjamin L, Corbett E, Connor M et al (2016) HIV, antiretroviral treatment, and stroke in Malawian adults. Neurology 86:324–333

    Article  CAS  Google Scholar 

  • Benjamin LA, Bryer A, Lucas S et al (2016) Arterial ischemic stroke in HIV. Neurol - Neuroimmunol Neuroinflammation 3:e254

    Article  Google Scholar 

  • Chetty R, Batitang S, Nair R (2000) Large artery vasculopathy in HIV-positive patients: another vasculitic enigma. Hum Pathol 31:374–379

    Article  CAS  Google Scholar 

  • Chow FC, Regan S, Feske S et al (2012) Comparison of ischemic stroke incidence in HIV-infected and non–HIV-infected patients in a US health care system. JAIDS J Acquir Immune Defic Syndr 60:351–358

    Article  Google Scholar 

  • Crowe SM, Westhorpe CLV, Mukhamedova N et al (2010) The macrophage: the intersection between HIV infection and atherosclerosis. J Leukoc Biol 87:589–598

    Article  CAS  Google Scholar 

  • Connor RI, Chen BK, Choe S et al (1995) Vpr is required for efficient replication of HIV-1.pdf. Virology 206: 935–44.

  • Dampier W, Nonnemacher MR, Mell J et al (2016) HIV-1 genetic variation resulting in the development of new quasispecies continues to be encountered in the peripheral blood of well-suppressed patients. PLoS ONE 11:e0155382

    Article  Google Scholar 

  • Dampier W, Antell GC, Aiamkitsumrit B et al (2017) Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status. J Neurovirol 23:113–124

    Article  CAS  Google Scholar 

  • de Larranaga GF, Alejandro Petroni GD, Alonso BSS et al (2003) Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients. Blood Coagul Fibrinolysis 14:15–18

    Article  Google Scholar 

  • De Oliveira T, Deforche K, Cassol S et al (2014) REGA HIV-1 Subtyping Tool - Version 3.0, http://dbpartners.stanford.edu:8080/RegaSubtyping/stanford-hiv/typingtool/ (accessed 31 July 2017).

  • Dumas A, Lê-Bury G, Marie-Anaïs F et al (2015) The HIV-1 protein Vpr impairs phagosome maturation by controlling microtubule-dependent trafficking. J Cell Biol 211:359–372

    Article  CAS  Google Scholar 

  • Feinstein MJ, Bogorodskaya M, Bloomfield GS et al (2016) Cardiovascular complications of HIV in endemic countries. Curr Cardiol Rep 18:113

    Article  Google Scholar 

  • Ferrucci A, Nonnemacher MR, Wigdahl B (2011) Human immunodeficiency virus viral protein R as an extracellular protein in neuropathogenesis. Adv Virus Res 81:165–199

    Article  CAS  Google Scholar 

  • Goh WC, Rogel ME, Matthew Kinsey C et al (1998) HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat Med 4:65–71

    Article  CAS  Google Scholar 

  • González ME (2017) The HIV-1 vpr protein: a multifaceted target for therapeutic intervention. Int J Mol Sci 18:1–21

    Google Scholar 

  • Graham SM, Rajwans N, Jaoko W et al (2013) Endothelial activation biomarkers increase after HIV-1 acquisition: plasma VCAM-1 predicts disease progression. AIDS 27:1803–1813

    Article  CAS  Google Scholar 

  • Grome HN, Barnett L, Hagar CC et al (2017) Association of T cell and macrophage activation with arterial vascular health in HIV. AIDS Res Hum Retroviruses 33:181–186

    Article  CAS  Google Scholar 

  • Grundy SM, Stone NJ, Chair V et al (2018) Cholesterol Clinical Practice Guidelines. Epub ahead of print 2018. https://doi.org/10.1161/CIR.0000000000000625.

  • Guenzel CA, Herate C, Le Rouzic E et al (2012) Recruitment of the nuclear form of uracil DNA glycosylase into virus particles participates in the full infectivity of HIV-1. J Virol 86:2533–2544

    Article  CAS  Google Scholar 

  • Guenzel CA, Hérate C, Benichou S (2014) HIV-1 Vpr-a still ‘enigmatic multitasker.’ Front Microbiol 5:1–13

    Article  Google Scholar 

  • Hansen L, Parker I, Sutliff RL et al (2013) Endothelial dysfunction, arterial stiffening, and intima-media thickening in large arteries from HIV-1 transgenic mice. Ann Biomed Eng 41:682–693

    Article  Google Scholar 

  • Jacquot G, Le Rouzic E, Maidou-Peindara P et al (2009) Characterization of the molecular determinants of primary HIV-1 Vpr proteins: Impact of the Q65R and R77Q substitutions on Vpr functions. PLoS One; 4. Epub ahead of print https://doi.org/10.1371/journal.pone.0007514.

  • Kamori D, Hasan Z, Ohashi J et al (2017) Identification of two unique naturally occurring Vpr sequence polymorphisms associated with clinical parameters in HIV-1 chronic infection. J Med Virol 89:123–129

    Article  CAS  Google Scholar 

  • Kline ER, Sutliff RL (2008) The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction. J Investig Med 56:752–769

    Article  CAS  Google Scholar 

  • Korber B, Myers G (1992) Signature pattern analysis: a method for assessing viral sequence relatedness. AIDS Res Hum Retroviruses 8:1549–1560

    Article  CAS  Google Scholar 

  • Libby P, Okamoto Y, Rocha VZ et al (2010) Inflammation in atherosclerosis: transition from theory to practice. Circ J 74:213–220

    Article  CAS  Google Scholar 

  • Promega Corporation. Promega Usage Information. Madison, USA: Promega Corporation (2013) https://worldwide.promega.com/-/media/files/resources/protocols/product-information-sheets/g/gotaq-flexi-dna-polymerase-m830.pdf .

  • Romani B, Engelbrecht S (2009) Human immunodeficiency virus type 1 Vpr: functions and molecular interactions. J Gen Virol 90:1795–1805

    Article  CAS  Google Scholar 

  • Roux P, Alfieri C, Hrimech M et al (2000) Activation of transcription factors NF-kappa B and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression. J Virol 74:4658–4665

    Article  CAS  Google Scholar 

  • Turner MD, Nedjai B, Hurst T et al (2014) Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta - Mol Cell Res 1843:2563–2582

    Article  CAS  Google Scholar 

  • Vodicka MA, Koepp DM, Silver PA et al (1998) HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev 12:175–185

    Article  CAS  Google Scholar 

  • Wang T, Yi R, Green LA et al (2015) Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat. Cardiovasc Pathol 24:279–282

    Article  Google Scholar 

  • Yin L, Liu L, Sun Y et al (2012) High-resolution deep sequencing reveals biodiversity, population structure, and persistence of HIV-1 quasispecies within host ecosystems. Retrovirology 9:108

    Article  CAS  Google Scholar 

Download references

Funding

KM was funded by the Discovery Foundation Academic Fellowship Award and the South African Medical Association Research Master’s Scholarship. MIC was funded by the South African National Research Foundation “Incentive Funding for Rated Researchers” scheme: Grant number 85526.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kate McMullen.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

McMullen, K., Bateman, K., Stanley, A. et al. Viral protein R polymorphisms in the pathogenesis of HIV-associated acute ischaemic stroke: a case–control study. J. Neurovirol. 27, 137–144 (2021). https://doi.org/10.1007/s13365-020-00936-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13365-020-00936-y

Keywords

Navigation